NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

The reality is you have PR’s from UCLA referring to trials using ATL-DC as DCVax-L, countless presentations by Dr. Liau presenting these results early, within her discussion of DCVax-L, clearly referring to it as the same vaccine, and numerous discussions everywhere confirming that fact. Because it is not a sponsored trial, they are simply using the pre-branding, generic descriptor for what has become labeled DCVax-L when NWBO is the sponsor.

But we realize with your desperation, having lied for years and years, you can’t accept that DCVax-L is still being very beautifully validated by UCLA on an ongoing basis and now has affirmation in Nature, with astonishing results. I understand that this makes your brain hurt. But reality can do that to people who live in a state of non-stop denial.

This is a problem for people who cannot accept reality. But reality is materializing, right before your eyes. Get ready for more reality, because it is coming. You can bet this data was and will be part of future applications. And Dr. Liau is on the SAB, so you can expect she will be there to explain as well.